Navigation Links
Rigel to Present at Three Upcoming Investor Conferences
Date:2/28/2011

SAN FRANCISCO, Feb. 28, 2011 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at three investment conferences during the month of March.  Details of each conference are as follows:Citi Global Health Care ConferenceDate:  Wednesday, March 2nd at 1:30 p.m. ETLocation:  New York, NY Cowen and Company 31st Annual Health Care ConferenceDate:  Tuesday, March 8th at 1:20 p.m. ETLocation:  Boston, MA Barclays Capital Global Healthcare ConferenceDate:  Thursday, March 17th at 10:45 a.m. ETLocation:  Miami Beach, FLAll three presentations will be webcast.  To access live audio webcast or subsequent archived recording, log on to www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (www.rigel.com)Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral syk inhibitor that has started its phase 3 clinical trial program for RA (with AstraZeneca), and R343, an inhaled syk inhibitor in clinical trials for asthma (with Pfizer).

Contact: Ryan MaynardPhone: 650.624.1284Email: invrel@ri
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Rigel Announces Participation at Two Investor Conferences
2. Rigel to Present at JP Morgan Healthcare Conference
3. Rigel Announces Third Quarter 2009 Financial Results
4. Rigel Announces Presentations at Two Investor Conferences
5. Rigels R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
6. Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis
7. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
8. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
9. Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
10. Rigels R788 Phase 2a Results Published in Arthritis and Rheumatism
11. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... HONOLULU , Sept. 15, 2014  Patients in ... specialty care more frequently in an outpatient setting versus ... the curve and to ensure that patients continue to ... today the launch of its new internal medicine residency ... practice more often in office, clinic and even virtual ...
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire-iReach/ -- Asthma ... persons of all ages, but most commonly starts ... characterized by narrowing of the airways, leading to ... lungs come into contact with endogenous and exogenous ... events, such as swelling of the airways, tightening ...
(Date:9/15/2014)... 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... owned subsidiary, Valeant Pharmaceuticals International, will redeem all of ... 6.75% Senior Notes due 2017, CUSIP Nos. 91911XAL8, U9098VAD4 ... has mailed an irrevocable notice of redemption for the ... of the irrevocable notice of redemption with respect to ...
Breaking Medicine Technology:Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 2Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 4Asthma Market to Reach 161.02 million Cases in 10MM by 2023 5Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 2
(Date:9/15/2014)... -- U.S. heart experts recommend doctors use a 14-point ... people for underlying heart disease that could result in ... the American College of Cardiology said in a joint ... history along with a physical examination can help identify ... risks for sudden cardiac death. The statement, ...
(Date:9/15/2014)... (PRWEB) September 16, 2014 “Canada ... market data on the Canada Gynecological Devices market. ... dollars, volume (in units) and average prices (in ... Female Sterilization Devices (Transcervical Sterilization Devices ... Rings) , Endometrial Ablation Devices (Thermal ...
(Date:9/15/2014)... HealthDay Reporter MONDAY, ... about twice as often as they,re actually needed for ... indicates. More than 11 million antibiotic prescriptions written ... according to researchers from University of Washington and Seattle ... to eradicate children,s viral illnesses, researchers said, but supports ...
(Date:9/15/2014)... 2014 As Colorado's historic experiment ... first full year, there are a variety of ... the evolution of its marketing and branding. , ... by Denver's Kindman, one of the state's most ... Kindman has pioneered the first-ever branded and pre-packaged ...
(Date:9/15/2014)... Physicians and clinicians from around ... at the Lowes Coronado Bay Resort for the ... . This CME accredited medical conference ... healthcare professionals—about the nutritional science that overwhelmingly supports ... its proven ability to prevent, suspend and, often, ...
Breaking Medicine News(10 mins):Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 2Health News:Heart Docs Don't Recommend Routine ECGs for Young Athletes 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 2Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 3Health News:Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org 4Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 2Health News:Kids Prescribed Antibiotics Twice as Often as Needed, Study Finds 3Health News:Colorado Company Unveils Innovative Line of Pre-packaged Cannabis Products 2Health News:Colorado Company Unveils Innovative Line of Pre-packaged Cannabis Products 3Health News:San Diego Plays Host This Week to International Plant-based Nutrition Healthcare Conference Featuring Drs. Ornish, Esselstyn, Campbell and Other Leading Experts 2Health News:San Diego Plays Host This Week to International Plant-based Nutrition Healthcare Conference Featuring Drs. Ornish, Esselstyn, Campbell and Other Leading Experts 3
... the European Journal of Cancer Care has shown that children ... of leukemia . ,As part of their study, researchers ... sophisticated meta-analysis of 17 research papers covering 136 nuclear sites ... Spain. ,Findings revealed that death rates for children ...
... without a Chinese link. Following reports of botulism outbreak, hot ... withdrawn in USA. ,This is the first ... decades. ,Health officials asked consumers and stores to ... and Austex . ,Two Texas children and an ...
... major crackdown on them, erring doctors and ... million for rorting the federal health system, since ... Service Review, (PSR) which investigates and punishes health practitioners ... (PBS) drugs inappropriately, carried out the search. ...
... James Mullen is not a happy man. The Cambridge biotechnology ... to use its drug Tysabri to treat patients with ... from drug trials that were included in an application to ... need more development". Now, an additional clinical trial proposed ...
... that a particular genetic variation may be tied to ... ,Known medically as premenstrual dysphoric disorder, or PMDD, ... in their childbearing years. It's characterized by bouts of ... second half of the menstrual cycle. These symptoms settle ...
... Researchers have revealed that combining a non-pyrethroid insecticide, ... to be an effective insecticide-repellent synergy against ... ,A combination of the two had proved ... addition of their respective properties. Mosquito nets soaked ...
Cached Medicine News:Health News:People Living Near Nuke Facilities at Higher Risk of Leukemia 2Health News:Chilly Sauce Linked to Botulism, Forcing Recall in US 2Health News:Chilly Sauce Linked to Botulism, Forcing Recall in US 3Health News:Rorting Health Practioners Busted 2Health News:MS Drug Fails The Test For Treating Crohns Disease 2Health News:Genetic Variation may Increase Premenstrual Depression Risk 2Health News:Genetic Variation may Increase Premenstrual Depression Risk 3Health News:Insecticide and Repellent Combo Effective in Eliminating Malarial Mosquitoes 2
... Bard® Biopsy Instrument and Needle is specially ... goal: a large quality, reliable core sample. ... featuring ultra-sharp tips and polished surfaces for ... of biopsy systems and needle sizes assures ...
... to bring efficiency and quality to routine ... superior technology of fluorescent flow cytometry with ... sampling or batch processing are easily accommodated ... in high volume laboratories. Fluorescent flow ...
... The iQ200 System incorporates the ... and the AUTION MAX™ AX-4280 Automated ... a fully integrated chemical and microscopic ... (APR™), a well trained neural network, ...
... UF-100 is designed to bring efficiency and ... It combines the superior technology of fluorescent ... analysis. Continuous sampling or batch processing ... streamlining sample processing in high volume laboratories. ...
Medicine Products: